E Alexanderson-Rosas, A G Monroy-Gonzalez, Luis Eduardo Juarez-Orozco, M M Martinez-Aguilar, E Estrada, I Soldevilla, O Garcia-Pérez, M E Soto-Lopez
Journal: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2018;24(5):1674-1679
PMID: 27506703
BACKGROUND
While F-fluorodeoxyglucose and F-sodium fluoride with positron emission tomography relate with inflammation and calcification, their role in the assessment of patients with Takayasu arteritis has not yet been studied.
METHODS
We present 5 patients with suspected active metabolic disease who underwent PET with F-fluorodeoxyglucose and F-sodium fluoride in order to explore the locations and correlations of F-fluorodeoxyglucose and F-sodium fluoride uptakes. Diagnosis of metabolic active disease was based on F-fluorodeoxyglucose uptake.
RESULTS
We studied 3 female patients and 2 male patients. Median age was 29 years (min: 19 max: 63). In areas with atherosclerotic plaques, we found a negative correlation between F-sodium fluoride and F-fluorodeoxyglucose uptakes (r = -0.78) (P = .001). Meanwhile, in areas with only metabolic active disease, we found a positive correlation between F-sodium fluoride and F-fluorodeoxyglucose uptakes (r = 0.94) (P = .019).
CONCLUSIONS
In Takayasu arteritis, F-sodium fluoride uptake can document different stages of metabolic disease, even in the absence of active metabolic disease or symptoms.
Other Literature Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.